Person profile
Address
Newark, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Jasper Therapeutics, Inc.
10 Jun 24
4
Revance Therapeutics, Inc.
3 May 24
4
ArriVent Biopharma, Inc.
29 Jan 24
3
ArriVent Biopharma, Inc.
25 Jan 24
4
Jasper Therapeutics, Inc.
8 Jun 23
4
Revance Therapeutics, Inc.
5 May 23
4
POLARITYTE, INC.
17 Jan 23
4
Jasper Therapeutics, Inc.
13 Oct 22
4
POLARITYTE, INC.
4 Oct 22
4/A
Revance Therapeutics, Inc.
13 May 22
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Jun 24 | JSPR Jasper Therapeutics | Stock Option Voting Common Stock | Grant | Acquire A | No | No | 25.41 | 7,500 | 190.58 k | 7,500 |
| 1 May 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 15,000 | 0.00 | 43,606 |
| 1 May 24 | RVNC Revance Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.795 | 23,458 | 89.02 k | 23,458 |
| 25 Jan 24 | AVBP ArriVent BioPharma, Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 18 | 17,884 | 321.91 k | 17,884 |
| 7 Jun 23 | JSPR Jasper Therapeutics | Stock Option Voting Common Stock | Grant | Acquire A | No | No | 1.6 | 47,000 | 75.20 k | 47,000 |